Statins were associated with better clinical outcomes in malignant pleural mesothelioma and advanced non-small-cell lung cancer patients treated with programmed cell death-1 (PD-1) inhibitors in a retrospective study [179]. The gene discussed is PDCD1; the disease is malignant pleural mesothelioma.